Abstract
We have analysed pre-transplant cytogenetic findings in 418 patients with CML in pre-blastic phase who underwent allogeneic BMT between February 1981 and January 1998. Five different patient groups were identified: A = Philadelphia (Ph)+; B = Ph−, BCR-ABL+; C = variant Ph (VPh); D = Ph chromosome plus at least one of: trisomy 8, +Ph, chromosome 17 abnormalities and E = other abnormalities in addition to the Ph chromosome. There were two principal conclusions. Firstly, Ph− patients showed a better outcome, and VPh patients a worse outcome, than those with a standard Ph, both in terms of leukaemia-free survival (LFS) (76.9%, 22.1% and 31.9%) and the risk of treatment failure relative to those with a standard Ph (relative risks of 0.49 and 1.92, respectively). One contributing factor may be relapse: no Ph− patients relapsed, whereas all other groups showed similar probabilities of relapse at 5 years (range 33.0–44.0%). Secondly, those with the additional changes of +8, +Ph and i(17q) did not show a worse outcome than those with no additional changes (5 year survival of 44.7% vs 51.8%; 5 year LFS of 40.6% vs 31.9%), whereas those with other additional changes may fare worst of all (40.4% and 16.0%, respectively). Bone Marrow Transplantation (2000) 25, 143–146.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Clift RA, Anasetti C . Allografting for chronic myeloid leukaemia Baillière's Clin Haematol 1997 10: 319–336
Przepiorka D, Thomas ED . Prognostic significance of cytogenetic abnormalities in patients with chronic myelogenous leukemia Bone Marrow Transplant 1988 3: 113–119
Slovak ML, Kopecky KJ, Wolman SR et al. Cytogenetic correlation with disease status and treatment outcome in advanced stage leukemia post bone marrow transplantation: a Southwest Oncology Group study (SWOG-8612) Leukemia Res 1995 19: 381–388
Savage DG, Szydlo RM, Chase A et al. Bone marrow transplantation for chronic myeloid leukaemia: the effects of differing criteria for defining disease phase on probabilities of survival and relapse Br J Haematol 1997 99: 30–35
Rooney DE, Czepulkowski BH (eds) . Human Cytogenetics: A Practical Approach v.II Oxford University Press: New York 1992
Webber L, Garson OM . Fluorodeoxyuridine synchronization of bone marrow cultures Cancer Genet Cytogenet 1983 8: 123–132
ISCN An International System for Human Cytogenetics Nomenclature. Mitelman F (ed) S Karger: Basel 1995
Kaplan EL, Meier P . Non parametric estimation from incomplete observations J Am Stat Assoc 1958 53: 457–481
Gooley TA, Leisenrin W, Crowley J, Storer BE . Estimation of failure probabilities in the presence of competing risks: new representations of old estimators Stats Med 1999 18: 695–706
Potter AM, Watmore AE, Cooke P et al. Significance of non-standard Philadelphia chromosomes in chronic granulocytic leukaemia Br J Cancer 1981 44: 51–54
O'Brien S, Thall PF, Siciliano MJ . The cytogenetics of chronic myelogenous leukaemia Baillière's Clin Haematol 1997 10: 259–276
Mitelman F . The cytogenetic scenario of chronic myeloid leukemia Leuk Lymphoma 1993 11: 11–15
Popenoe DW, Schaefer-Rego K, Mears JG et al. Frequent and extensive deletion during the 9;22 translocation in CML Blood 1986 68: 1123–1128
Sinclair, PB, Leversha M, Telford N et al. Chromosome 9 deletions accompany both standard and variant Ph translocations Br J Haematol 1998 101: (Suppl.1) 60 (Abstr.151)
Clift RA, Buckner CD, Thomas ED . Marrow transplantation for patients in accelerated phase of chronic myeloid leukemia Blood 1994 84: 4368–4373
Acknowledgements
This work was supported by the Leukaemia Research Fund.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Konstantinidou, P., Szydlo, R., Chase, A. et al. Cytogenetic status pre-transplant as a predictor of outcome post bone marrow transplantation for chronic myelogenous leukaemia. Bone Marrow Transplant 25, 143–146 (2000). https://doi.org/10.1038/sj.bmt.1702133
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702133